This study presents the case of a late clinical leaflet thrombosis 1.5 years after percutaneous aortic valve replacement, despite adequate non-vitamin K anticoagulant therapy. Optimal antithrombotic therapy after transcatheter aortic valve replacement remains undetermined. After switching to vitamin K antagonist therapy, complete resolution occurred at 3 months follow-up. ().
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387837 | PMC |
| http://dx.doi.org/10.1016/j.jaccas.2021.06.012 | DOI Listing |
Publication Analysis
Top Keywords
aortic valve
12
valve replacement
12
late clinical
8
transcatheter aortic
8
replacement despite
8
non-vitamin anticoagulant
8
valve
4
clinical valve
4
valve thrombosis
4
thrombosis transcatheter
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!